C. Marc Richards - 09 Aug 2024 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: EVP, Chief Financial Officer
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Issuer symbol: MD
Transactions as of: 09 Aug 2024
Net transactions value: -$504,000
Form type: 4
Filing time: 13 Aug 2024, 17:00:03 UTC
Previous filing: 04 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	$328,225	-32,562	-14%	$10.08	192,785	09 Aug 2024	Direct	F1
transaction	MD	Common Stock	Sale	$175,775	-17,438	-9%	$10.08	175,347	12 Aug 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices randing from $10.01 to $10.23 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $10.00 to $10.17 for a weighted average sales price of $10.08. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securiites and Exchange Commission upon request, full information regarding the number of shares sold at each seperate price within the range set forth in this footnote.